Orchid Chemicals & Pharmaceuticals receives Establishment Inspection Report (EIR) from USFDA
For its formulation manufacturing facility in Sriperumbudur
Orchid Chemicals & Pharmaceuticals announced that Orchid received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection closure for the formulation manufacturing facility located at Irungattukottai, Sriperumbudur, Kancheepuram District, India. The facility was inspected by USFDA in the month of May 2015.Powered by Capital Market - Live News